CCL5 was mainly expressed in the tertiary lymphoid structure (TLS), whereas CYP1A1 was predominantly expressed in the remaining active tumor cells, especially those adjacent to TLS (Figure 5K,M). This evidence concerns the gene CYP1A1 and neoplasm.